Naeem S, Zhang J, Zhang Y, Wang Y
Mol Ther Nucleic Acids. 2025; 36(1):102440.
PMID: 39897578
PMC: 11786870.
DOI: 10.1016/j.omtn.2024.102440.
Kiran Kumar K, Singh S, Schmelzle S, Vogel P, Fruhner C, Hanswillemenke A
Nat Commun. 2024; 15(1):6615.
PMID: 39103360
PMC: 11300799.
DOI: 10.1038/s41467-024-50395-w.
Di M, Lv J, Jing Z, Yang Y, Yan K, Wu J
Mol Ther Nucleic Acids. 2024; 35(2):102190.
PMID: 38721279
PMC: 11077028.
DOI: 10.1016/j.omtn.2024.102190.
Song J, Zhuang Y, Yi C
Nat Chem Biol. 2024; 20(3):277-290.
PMID: 38418907
DOI: 10.1038/s41589-023-01531-y.
Schmitt-Ulms C, Kayabolen A, Manero-Carranza M, Zhou N, Donnelly K, Nuccio S
bioRxiv. 2024; .
PMID: 38352602
PMC: 10862893.
DOI: 10.1101/2024.01.31.578223.
CRISPR technologies for genome, epigenome and transcriptome editing.
Villiger L, Joung J, Koblan L, Weissman J, Abudayyeh O, Gootenberg J
Nat Rev Mol Cell Biol. 2024; 25(6):464-487.
PMID: 38308006
DOI: 10.1038/s41580-023-00697-6.
Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications.
Weng S, Yang X, Yu N, Wang P, Xiong S, Ruan H
Int J Mol Sci. 2024; 25(1).
PMID: 38203521
PMC: 10779106.
DOI: 10.3390/ijms25010351.
Dissecting the basis for differential substrate specificity of ADAR1 and ADAR2.
Zambrano-Mila M, Witzenberger M, Rosenwasser Z, Uzonyi A, Nir R, Ben-Aroya S
Nat Commun. 2023; 14(1):8212.
PMID: 38081817
PMC: 10713624.
DOI: 10.1038/s41467-023-43633-0.
Precision RNA base editing with engineered and endogenous effectors.
Pfeiffer L, Stafforst T
Nat Biotechnol. 2023; 41(11):1526-1542.
PMID: 37735261
DOI: 10.1038/s41587-023-01927-0.
RNA Overwriting of Cellular mRNA by Cas13b-Directed RNA-Dependent RNA Polymerase of Influenza A Virus.
Ogasawara S, Ebashi S
Int J Mol Sci. 2023; 24(12).
PMID: 37373148
PMC: 10298375.
DOI: 10.3390/ijms241210000.
Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?.
Bellingrath J, McClements M, Fischer M, MacLaren R
Front Mol Neurosci. 2023; 16:1092913.
PMID: 37293541
PMC: 10244592.
DOI: 10.3389/fnmol.2023.1092913.
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
Koonin E, Gootenberg J, Abudayyeh O
Biochemistry. 2023; 62(24):3465-3487.
PMID: 37192099
PMC: 10734277.
DOI: 10.1021/acs.biochem.3c00159.
Identification of exceptionally potent adenosine deaminases RNA editors from high body temperature organisms.
Avram-Shperling A, Kopel E, Twersky I, Gabay O, Ben-David A, Karako-Lampert S
PLoS Genet. 2023; 19(3):e1010661.
PMID: 36877730
PMC: 10019624.
DOI: 10.1371/journal.pgen.1010661.
Nucleoside analogs in ADAR guide strands targeting 5'-UA̲ sites.
Brinkman H, Matos V, Mendoza H, Doherty E, Beal P
RSC Chem Biol. 2023; 4(1):74-83.
PMID: 36685257
PMC: 9811522.
DOI: 10.1039/d2cb00165a.
RNA editing: Expanding the potential of RNA therapeutics.
Booth B, Nourreddine S, Katrekar D, Savva Y, Bose D, Long T
Mol Ther. 2023; 31(6):1533-1549.
PMID: 36620962
PMC: 9824937.
DOI: 10.1016/j.ymthe.2023.01.005.
In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations.
Psatha N, Paschoudi K, Papadopoulou A, Yannaki E
Genes (Basel). 2022; 13(12).
PMID: 36553489
PMC: 9778055.
DOI: 10.3390/genes13122222.
Programmable eukaryotic protein synthesis with RNA sensors by harnessing ADAR.
Jiang K, Koob J, Chen X, Krajeski R, Zhang Y, Volf V
Nat Biotechnol. 2022; 41(5):698-707.
PMID: 36302988
DOI: 10.1038/s41587-022-01534-5.
Site-directed RNA editing by harnessing ADARs: advances and challenges.
Li M, Yan C, Jiao Y, Xu Y, Bai C, Miao R
Funct Integr Genomics. 2022; 22(6):1089-1103.
PMID: 36282404
DOI: 10.1007/s10142-022-00910-3.
RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease.
Birgaoanu M, Sachse M, Gatsiou A
Cardiovasc Drugs Ther. 2022; 37(2):401-411.
PMID: 36239832
PMC: 9561330.
DOI: 10.1007/s10557-022-07391-3.
Targeted RNA editing in brainstem alleviates respiratory dysfunction in a mouse model of Rett syndrome.
Sinnamon J, Jacobson M, Yung J, Fisk J, Jeng S, McWeeney S
Proc Natl Acad Sci U S A. 2022; 119(33):e2206053119.
PMID: 35939700
PMC: 9388114.
DOI: 10.1073/pnas.2206053119.